Bull Hedging
  • Politics
  • Stocks
  • Business
  • Investing
  • Politics
  • Stocks
  • Business
  • Investing

Bull Hedging

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024
December 20, 2024
RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

previous post
Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation
next post
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

Related Posts

Sankamap Updates Status on Late Filing of Financial...

December 4, 2025

Grande Portage Applies for Road Easement from State...

August 23, 2025

Red Metal Resources Planning 2025 Work Program on...

February 20, 2025

Fund Manager: Gold Stocks a Strategic Opportunity for...

May 21, 2025

Cygnus Starts Trading on OTCQB Market

February 15, 2025

Mali Enforces Gold Seizure at Barrick’s Loulo-Gounkoto Mine

January 14, 2025

Yvonne Blaszczyk: Gold Still Far from “Ultimate High,”...

January 9, 2026

Lode Gold Closes $350,000 Financing

January 1, 2025

CNN Fear and Greed Index Plunges to Lowest...

April 12, 2025

Charbone Hydrogen

September 22, 2025

Recent Posts

  • The Real Drivers of This Market: AI, Semis & Robotics
  • S&P 500 Breaking Out Again: What This Means for Your Portfolio
  • Capitol police arrest Rubio hearing disruptor, as Republican senator says ‘off to jail’
  • Trump calls on employers nationwide to match contributions into workers’ kids’ Trump Accounts
  • Rubio warns NATO allies US is ‘not simply focused on Europe,’ doesn’t have unlimited resources

Recent Comments

No comments to show.

About Us

About Us

Design Magazine

Welcome to Design Magazine. Follow us for daily & updated design tips, guide and knowledge.

Stay Connect

Facebook Twitter Instagram Pinterest Youtube Email

Recent Posts

  • The Real Drivers of This Market: AI, Semis & Robotics

    January 29, 2026

  • S&P 500 Breaking Out Again: What This Means for Your Portfolio

    January 29, 2026

  • Capitol police arrest Rubio hearing disruptor, as Republican senator says ‘off to jail’

    January 29, 2026

  • Trump calls on employers nationwide to match contributions into workers’ kids’ Trump Accounts

    January 29, 2026

  • Rubio warns NATO allies US is ‘not simply focused on Europe,’ doesn’t have unlimited resources

    January 29, 2026

  • Gulf shipping operations grind to halt near Iran, US quietly prepares for possible strike: ‘Heightened risk’

    January 29, 2026

Editors’ Picks

  • 1

    Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test

    September 19, 2025
  • 2

    Small Caps are Set to Skyrocket in 2025—Here’s What You Need to Know

    December 12, 2024
  • 3

    Trump leaves China guessing what his next move is with unusual inauguration invitation

    December 15, 2024
  • 4

    Ad revenue should stabilize for media companies in 2025 — if they have sports

    December 31, 2024
  • 5

    Zinc Stocks: 4 Biggest Canadian Companies in 2025

    January 15, 2025
  • 6

    Uranium Price Forecast: Top Trends That Will Affect Uranium in 2025

    December 19, 2024
  • 7

    Lead Price Forecast: Top Trends for Lead in 2025

    January 11, 2025
Promotion Image

banner

Categories

  • Business (607)
  • Investing (2,913)
  • Politics (3,568)
  • Stocks (1,054)
  • About us
  • Contacts
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Copyright © 2026 bullhedging.com | All Rights Reserved